← Evidence map

ArticleMolecules (Basel, Switzerland)2026

5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.

Kyu-Seok Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. | OpenQuestion